ERIS Lifesciences standalone net profit rises 39.38% in the September 2017 quarter
Sales rise 14.78% to Rs 222.06 crore
Net profit of ERIS Lifesciences rose 39.38% to Rs 92.30 crore in the quarter ended September 2017 as against Rs 66.22 crore during the previous quarter ended September 2016. Sales rose 14.78% to Rs 222.06 crore in the quarter ended September 2017 as against Rs 193.47 crore during the previous quarter ended September 2016. ParticularsQuarter EndedSep. 2017Sep. 2016% Var.Sales222.06193.47 15 OPM %42.9737.53 -PBDT102.3379.56 29 PBT97.8374.28 32 NP92.3066.22 39Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content